Hui Li
7PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 06, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies.Sizhe Yu, Hui Li, Hongyang Lu
|Mar 11, 2025
Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice.Zhenzhen Wen, Tong Liu, Xutao Xu
|Feb 12, 2024
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts.Yanjun Xu, Kaibo Ding, Zhongsheng Peng
|Dec 21, 2022
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer.Hui Li, Yongchang Zhang, Yanjun Xu
|Sep 26, 2022
E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2.Hui Li, Ning Wang, Yu Jiang
|Oct 01, 2021
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China.Jiamin Sheng, Hui Li, Xiaoqing Yu
Pageof 2
